The Beauty Health Company (NASDAQ:SKIN) Receives $1.38 Average PT from Analysts

The Beauty Health Company (NASDAQ:SKIN) has been assigned a consensus recommendation of “Hold” from the seven analysts that are presently covering the firm, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, five have given a hold recommendation and one has issued a buy recommendation on the company. The average 1 year target price among analysts that have issued ratings on the stock in the last year is $1.3750.

SKIN has been the subject of several research analyst reports. Roth Capital reissued a “buy” rating and issued a $2.00 price objective (down from $2.50) on shares of Beauty Health in a research report on Wednesday, May 20th. Canaccord Genuity Group cut their target price on Beauty Health from $1.50 to $1.00 and set a “hold” rating on the stock in a research report on Friday, May 1st. Weiss Ratings cut Beauty Health from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Thursday, July 23rd. TD Cowen lowered their target price on Beauty Health from $1.00 to $0.90 and set a “hold” rating for the company in a report on Wednesday, August 12th. Finally, Zacks Research lowered Beauty Health from a “strong-buy” rating to a “hold” rating in a research note on Monday, July 20th.

Beauty Health Stock Performance

SKIN opened at $0.60 on Friday. Beauty Health has a twelve month low of $0.55 and a twelve month high of $2.69. The company has a quick ratio of 1.48, a current ratio of 1.76 and a debt-to-equity ratio of 4.36. The company has a fifty day moving average of $0.73 and a 200-day moving average of $0.87. The stock has a market cap of $78.08 million, a PE ratio of -2.73 and a beta of 1.07.

Beauty Health (NASDAQ:SKIN) last released its earnings results on Thursday, August 6th. The company reported ($0.02) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.02). The business had revenue of $72.11 million for the quarter, compared to analyst estimates of $74.45 million. Beauty Health had a negative net margin of 9.79% and a negative return on equity of 47.83%. On average, sell-side analysts predict that Beauty Health will post -0.16 EPS for the current year.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the stock. Capricorn Fund Managers Ltd acquired a new position in shares of Beauty Health during the first quarter valued at about $17,270,000. Diversified Trust Co acquired a new stake in shares of Beauty Health in the 1st quarter valued at about $25,000. MTM Investment Management LLC grew its stake in shares of Beauty Health by 114.0% in the 4th quarter. MTM Investment Management LLC now owns 26,218 shares of the company’s stock valued at $36,000 after buying an additional 13,968 shares during the period. CWM LLC increased its position in Beauty Health by 232.8% in the 4th quarter. CWM LLC now owns 22,018 shares of the company’s stock valued at $31,000 after buying an additional 15,402 shares in the last quarter. Finally, SG Americas Securities LLC increased its position in Beauty Health by 111.9% in the 4th quarter. SG Americas Securities LLC now owns 24,670 shares of the company’s stock valued at $34,000 after buying an additional 13,026 shares in the last quarter. Institutional investors and hedge funds own 93.26% of the company’s stock.

About Beauty Health

Beauty Health Company (NASDAQ: SKIN) is a U.S.-based consumer wellness and beauty enterprise that integrates device-based and product-based offerings across skin, body and hair wellness categories. The company operates a portfolio of established brands that blend professional and at-home solutions, focusing on innovative formulations and technologies to address a range of beauty and self-care needs. Through its proprietary e-commerce platforms and strategic retail partnerships, Beauty Health seeks to deliver premium experiences and tangible results to a global customer base.

Beauty Health’s brand portfolio includes Sol de Janeiro, known for its award-winning Brazilian Bum Bum Cream body care collection; Elemis, a U.K.-originated professional skin care line distributed in spas and skincare clinics; NuFACE and Dermaflash, two at-home beauty device brands specializing in microcurrent facial toning and gentle exfoliation respectively; and Nutrafol, a legal-strength hair wellness supplement clinically designed to support hair growth.